Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biodelivery Sciences buy stratec buy

Start price
Target price
Performance (%)

Comments by stratec for this prediction

In the thread Trading Biodelivery Sciences

Buy Biodelivery Sciences

Published on 14.08.19
Prediction Buy
Target price 5.000

Kursziel gesetzt auf 5,0

In the thread Biodelivery Sciences

The company continues to show impressive growth in BELBUCA scripts and sales. Recently acquired Symproic also seems to be off to a good start in the hand of BioDelivery as well. The company is on its way to achieving cash flow positive status by the close of this year. Selling at less than one times the eventual annual sales management believes it can achieve with BELBUCA and Symprioc, the shares remain cheap.